866-997-4948(US-Canada Toll Free)

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 129 Pages

Notes:
Sales, means the sales volume of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Revenue, means the sales value of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

This report studies sales (consumption) of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Astellas Pharmaceuticals
Actavis
Pfizer
GlaxoSmithKline
Salix Pharmaceuticals Ltd
AstraZenenca

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Preface
Eluxadoline
Alosetron
Rifaximin
Loperamide
Diphenoxylate + Atropine
Dicyclomine and Hyoscyamine
Split by applications, this report focuses on sales, market share and growth rate of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in each application, can be divided into
Hospitals
Clinics
Others

Table of Contents

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Report 2017
1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Overview
1.1 Product Overview and Scope of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
1.2 Classification of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
1.2.1 Preface
1.2.2 Eluxadoline
1.2.3 Alosetron
1.2.4 Rifaximin
1.2.5 Loperamide
1.2.6 Diphenoxylate + Atropine
1.2.7 Dicyclomine and Hyoscyamine
1.3 Application of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Others
1.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (2012-2022)
1.5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2022)
1.5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2022)

2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Competition by Manufacturers, Type and Application
2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Competition by Manufacturers
2.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Share by Manufacturers (2012-2017)
2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume and Value) by Type
2.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type (2012-2017)
2.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume and Value) by Regions
2.3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Regions (2012-2017)
2.3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Regions (2012-2017)
2.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume) by Application

3 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume, Value and Sales Price)
3.1 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Value (2012-2017)
3.1.1 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)
3.1.2 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)
3.1.3 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)
3.2 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Manufacturers
3.3 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type
3.4 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application

4 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume, Value and Sales Price)
4.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Value (2012-2017)
4.1.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)
4.1.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)
4.1.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)
4.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Manufacturers
4.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type
4.4 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application

5 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume, Value and Sales Price)
5.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Value (2012-2017)
5.1.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)
5.1.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)
5.1.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)
5.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Manufacturers
5.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type
5.4 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application

6 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume, Value and Sales Price)
6.1 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Value (2012-2017)
6.1.1 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)
6.1.2 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)
6.1.3 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)
6.2 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Manufacturers
6.3 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type
6.4 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application
7 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Value (2012-2017)
7.1.1 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Manufacturers
7.3 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type
7.4 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application
8 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume, Value and Sales Price)
8.1 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Value (2012-2017)
8.1.1 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)
8.1.2 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)
8.1.3 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)
8.2 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Manufacturers
8.3 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type
8.4 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application

9 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturers Analysis
9.1 Astellas Pharmaceuticals
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification
9.1.2.1 Preface
9.1.2.2 Eluxadoline
9.1.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Actavis
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification
9.2.2.1 Preface
9.2.2.2 Eluxadoline
9.2.3 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Pfizer
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification
9.3.2.1 Preface
9.3.2.2 Eluxadoline
9.3.3 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 GlaxoSmithKline
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification
9.4.2.1 Preface
9.4.2.2 Eluxadoline
9.4.3 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Salix Pharmaceuticals Ltd
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification
9.5.2.1 Preface
9.5.2.2 Eluxadoline
9.5.3 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 AstraZenenca
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification
9.6.2.1 Preface
9.6.2.2 Eluxadoline
9.6.3 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview

10 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Maufacturing Cost Analysis
10.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
10.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast (2017-2022)
14.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price and Trend Forecast (2017-2022)
14.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source


Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *